Comparative effectiveness of FOLFIRINOX or nab-paclitaxel plus gemcitabine in locally advanced or metastatic pancreatic cancer: A population-based analysis.

Ying Wang,Leo Chen,Pierre Camateros,Sharlene Gill,Daniel John Renouf,Winson Y. Cheung

Comparative effectiveness of FOLFIRINOX or nab-paclitaxel plus gemcitabine in locally advanced or metastatic pancreatic cancer: A population-based analysis.

2016

Ying Wang
Leo Chen
Pierre Camateros
Sharlene Gill
Daniel John Renouf
Winson Y. Cheung

6561Background: FOLFIRINOX (FFN), nab-paclitaxel plus gemcitabine (NG), and gemcitabine (gem) are 3 systemic therapies that provide clinically meaningful benefit to patients (pts) with unresectable...

Keywords:

Metastatic pancreatic cancer
Nab-paclitaxel
Pathology
Oncology
FOLFIRINOX
Gemcitabine
Population
Medicine
Internal medicine
population based
locally advanced

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations